Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hydrocortisone + salicylic acid is a combination topical medication used primarily for dermatological conditions such as psoriasis and seborrheic dermatitis. **Hydrocortisone** is a corticosteroid that acts by inhibiting the release of pro-inflammatory substances, thereby reducing redness, swelling, and itching. **Salicylic acid** is a keratolytic agent that softens and helps remove the outer layer of the skin, promoting desquamation and improving the penetration of hydrocortisone, which enhances its anti-inflammatory effect. This combination is usually formulated as a cream, ointment, or scalp lotion and is applied to affected skin areas to relieve inflammation, scaling, and pruritus[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hydrocortisone + salicylic acid.